Language:
English
繁體中文
Help
Login
Back
to Search results for
[ subject:"Drug Development." ]
Switch To:
Labeled
|
MARC Mode
|
ISBD
Preclinical drug development
~
Rogge, Mark C.
Preclinical drug development
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Preclinical drug development/ edited by Mark C. Rogge, David R. Taft.
other author:
Rogge, Mark C.
Published:
New York :Informa Healthcare, : c2010.,
Description:
1 online resource (viii, 359 p., [8] p. of plates) :ill. (some col.) ; : 27 cm.;
Subject:
Drug development. -
Online resource:
Connect to Informa resource
ISBN:
9781420084733 (electronic bk.)
Preclinical drug development
Preclinical drug development
[electronic resource] /edited by Mark C. Rogge, David R. Taft. - 2nd ed. - New York :Informa Healthcare,c2010. - 1 online resource (viii, 359 p., [8] p. of plates) :ill. (some col.) ;27 cm. - Drugs and the pharmaceutical sciences ;187. - Drugs and the pharmaceutical sciences ;v. 183-184.
Includes bibliographical references and index.
The scope of preclinical drug development : an introduction and framework / Mark C. Rogge -- Lead molecule selection : pharmaceutical profiling and toxicity assessments / P.L. Bullock -- Interspecies differences in physiology and pharmacology : extrapolating preclinical data to human populations / M.N. Martinez -- Pharmacokinetics/ADME of small molecules / A.D. Ajavon and David R. Taft -- Pharmacokinetics/ADME of large molecules / R. Braeckman -- Preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development / P.L. Bonate and P. Vicini -- Formulation and production strategies for enhancing bioavailability of poorly absorbed drugs / A.B. Watts and R.O. Williams III -- Transporters involved in drug disposition, toxicity, and efficacy / C.Q. Xia and G.T. Miwa -- Toxicity evaluations, ICH guidelines, and current practice / J.L. Larson -- Application of pathology in safety assessment / Robert A. Ettlin and David E. Prentice -- Utilizing the preclinical database to support clinical drug development / H. Lee.
ISBN: 9781420084733 (electronic bk.)
LCCN: 2009025807
Nat. Bib. No.: GBA967536bnb
Nat. Bib. Agency Control No.: 101508920DNLMSubjects--Topical Terms:
581824
Drug development.
LC Class. No.: RM301.25 / .P745 2010
Dewey Class. No.: 615/.19
National Library of Medicine Call No.: W1 / DR893B v.187 2010
Preclinical drug development
LDR
:02360cam a2200373 a 4500
001
684765
003
OCoLC
005
20111126222232.0
006
m d
007
cr cnu---unuuu
008
111216s2010 nyua sb 001 0 eng d
010
$a
2009025807
015
$a
GBA967536
$2
bnb
016
7
$a
101508920
$2
DNLM
016
7
$a
015307927
$2
Uk
019
$a
212853256
020
$a
9781420084733 (electronic bk.)
020
$a
9781420084726 (hardcover : alk. paper)
020
$a
1420084720 (hardcover : alk. paper)
035
$a
(OCoLC)416216136
$z
(OCoLC)212853256
035
$a
ocn416216136
040
$a
DNLM/DLC
$c
DLC
$d
BTCTA
$d
BAKER
$d
YDXCP
$d
NLM
$d
C#P
$d
MUQ
$d
UKM
$d
IG#
042
$a
pcc
050
0 0
$a
RM301.25
$b
.P745 2010
060
0 0
$a
W1
$b
DR893B v.187 2010
060
1 0
$a
QV 771
$b
P9227 2010
082
0 0
$a
615/.19
$2
22
245
0 0
$a
Preclinical drug development
$h
[electronic resource] /
$c
edited by Mark C. Rogge, David R. Taft.
250
$a
2nd ed.
260
$a
New York :
$b
Informa Healthcare,
$c
c2010.
300
$a
1 online resource (viii, 359 p., [8] p. of plates) :
$b
ill. (some col.) ;
$c
27 cm.
490
1
$a
Drugs and the pharmaceutical sciences ;
$v
187
504
$a
Includes bibliographical references and index.
505
0
$a
The scope of preclinical drug development : an introduction and framework / Mark C. Rogge -- Lead molecule selection : pharmaceutical profiling and toxicity assessments / P.L. Bullock -- Interspecies differences in physiology and pharmacology : extrapolating preclinical data to human populations / M.N. Martinez -- Pharmacokinetics/ADME of small molecules / A.D. Ajavon and David R. Taft -- Pharmacokinetics/ADME of large molecules / R. Braeckman -- Preclinical pharmacokinetic-pharmacodynamic modeling and simulation in drug development / P.L. Bonate and P. Vicini -- Formulation and production strategies for enhancing bioavailability of poorly absorbed drugs / A.B. Watts and R.O. Williams III -- Transporters involved in drug disposition, toxicity, and efficacy / C.Q. Xia and G.T. Miwa -- Toxicity evaluations, ICH guidelines, and current practice / J.L. Larson -- Application of pathology in safety assessment / Robert A. Ettlin and David E. Prentice -- Utilizing the preclinical database to support clinical drug development / H. Lee.
650
0
$a
Drug development.
$3
581824
650
6
$a
Maedicaments
$x
Daeveloppement.
$3
798663
650
1 2
$a
Drug Evaluation, Preclinical
$x
methods.
$3
583208
650
2 2
$a
Drug Industry
$x
methods.
$3
583209
700
1
$a
Rogge, Mark C.
$3
583210
700
1
$a
Taft, David R.
$3
583211
830
0
$a
Drugs and the pharmaceutical sciences ;
$v
v. 183-184
$3
777873
856
4
$z
Connect to Informa resource
$u
http://informahealthcare.com/action/showBook?doi=10.3109%2F9781420084733
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login